These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1020 related articles for article (PubMed ID: 6703733)

  • 21. Drug-induced lupus: an update on its dermatologic aspects.
    Marzano AV; Vezzoli P; Crosti C
    Lupus; 2009 Oct; 18(11):935-40. PubMed ID: 19762393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lupus erythematosus in children: a report of six cases.
    Fenniche S; Triki S; Benmously R; Marrak H; Ben Ammar F; Mokhtar I
    Dermatol Online J; 2005 Aug; 11(2):11. PubMed ID: 16150219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment.
    Jewell ML; McCauliffe DP
    J Am Acad Dermatol; 2000 Jun; 42(6):983-7. PubMed ID: 10827400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histopathologic findings in cutaneous lupus erythematosus.
    Bielsa I; Herrero C; Collado A; Cobos A; Palou J; Mascaró JM
    Arch Dermatol; 1994 Jan; 130(1):54-8. PubMed ID: 8285740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Photosensitivity in lupus erythematosus, UV photoprovocation results compared with history of photosensitivity and clinical findings.
    Hasan T; Nyberg F; Stephansson E; Puska P; Häkkinen M; Sarna S; Ros AM; Ranki A
    Br J Dermatol; 1997 May; 136(5):699-705. PubMed ID: 9205502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mast cells in systemic and cutaneous lupus erythematosus.
    Kaczmarczyk-Sekuła K; Dyduch G; Kostański M; Wielowieyska-Szybińska D; Szpor J; Białas M; Okoń K
    Pol J Pathol; 2015 Dec; 66(4):397-402. PubMed ID: 27003772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-induced lupus erythematosus.
    Marzano AV; Tavecchio S; Menicanti C; Crosti C
    G Ital Dermatol Venereol; 2014 Jun; 149(3):301-9. PubMed ID: 24819757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Chronic lupus erythematosus, subacute cutaneous lupus].
    Doutre MS; Beylot C
    Rev Prat; 1990 Sep; 40(21):1930-4. PubMed ID: 2237183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of antibody to C5b-9 in the subclassification of lupus erythematosus.
    Magro CM; Crowson AN; Harrist TJ
    Br J Dermatol; 1996 May; 134(5):855-62. PubMed ID: 8736325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoglobulin M predominance in cutaneous lupus erythematosus.
    Kontos AP; Jirsari M; Jacobsen G; Fivenson DP
    J Cutan Pathol; 2005 May; 32(5):352-5. PubMed ID: 15811120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Subacute cutaneous lupus erythematosus: clinical aspects, immunology and therapy].
    Ruzicka T; Bieber T; Meurer M
    Wien Klin Wochenschr; 1987 Dec; 99(23):802-7. PubMed ID: 3324494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral discoid lupus erythematosus. III. A histopathologic study of sixty-six patients.
    Schiødt M
    Oral Surg Oral Med Oral Pathol; 1984 Mar; 57(3):281-93. PubMed ID: 6584819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of skin disease in patients with lupus erythematosus.
    Callen JP
    Best Pract Res Clin Rheumatol; 2002 Apr; 16(2):245-64. PubMed ID: 12041952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutaneous localization of the membrane attack complex in discoid and systemic lupus erythematosus.
    Biesecker G; Lavin L; Ziskind M; Koffler D
    N Engl J Med; 1982 Feb; 306(5):264-70. PubMed ID: 7054697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subacute cutaneous lupus erythematosus: 25-year evolution of a prototypic subset (subphenotype) of lupus erythematosus defined by characteristic cutaneous, pathological, immunological, and genetic findings.
    Sontheimer RD
    Autoimmun Rev; 2005 Jun; 4(5):253-63. PubMed ID: 15990071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ARA and EADV criteria for classification of systemic lupus erythematosus in patients with cutaneous lupus erythematosus.
    Parodi A; Rebora A
    Dermatology; 1997; 194(3):217-20. PubMed ID: 9187836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical Study of the PD-1/PD-L1 Pathway in Cutaneous Lupus Erythematosus.
    Király Z; Szepesi Á; Sebestyén A; Kuroli E; Rencz F; Tóth B; Bokor L; Szakonyi J; Medvecz M; Hidvégi B
    Pathol Oncol Res; 2022; 28():1610521. PubMed ID: 35979531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of granzyme B-expressing CD-8-positive T cells in lymphocytic inflammatory infiltrate in cutaneous lupus erythematosus and in dermatomyositis.
    Grassi M; Capello F; Bertolino L; Seia Z; Pippione M
    Clin Exp Dermatol; 2009 Dec; 34(8):910-4. PubMed ID: 19456762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subacute cutaneous lupus erythematosus presenting as poikiloderma.
    Hughes R; Loftus B; Kirby B
    Clin Exp Dermatol; 2009 Dec; 34(8):e859-61. PubMed ID: 20055848
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 51.